Lineage Cell Therapeutics (LCTX) Debt Ratio (2014 - 2021)

Lineage Cell Therapeutics' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.0 for Q1 2021.

• On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.0 in Q1 2021; TTM through Mar 2021 was 0.0, a N/A change from a year earlier, with the FY2020 full-year figure at 0.0, changed N/A from the prior year.
• Debt Ratio eased to 0.0 in Q1 2021 per LCTX's latest filing, from 0.0 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.01 in Q3 2020 and bottomed at 0.0 in Q4 2017.
• The 3-year median for Debt Ratio is 0.0 (2021), against an average of 0.0.
• Biggest YoY gain for Debt Ratio was 70.37% in 2017; the steepest drop was 87.66% in 2017.
• Year by year, Debt Ratio stood at 0.0 in 2017, then jumped by 4562.96% to 0.0 in 2020, then slipped by 15.62% to 0.0 in 2021.
• Per Business Quant, the three latest LCTX Debt Ratio figures stand at 0.0 (Q1 2021), 0.0 (Q4 2020), and 0.01 (Q3 2020).